Private equity investment in healthcare reached an all-time high in 2022, with reports putting the overall deal value at a staggering $151 billion. But 2023 is shaping up to be a very different year, with investors pulling back as they try to figure out how long the landscape will be dominated by rising labor costs and interest rates. McDermott Will & Emery assess five trends to watch in private equity healthcare investing from their conversations with leading investors and bankers. Download the report.
Related Posts
Legal, Regulatory Uncertainty Could Slow Down Behavioral Health Dealmaking
On top of the market force headwinds, the Biden administration and some state governments have signaled that they will put greater scrutiny on health care M&A.
October 23, 2023
Proposed Medicare Advantage Cuts Would Increase Premiums, Decrease Growth Rate, BMA Says
Payers' estimates of a more than 2% payment cut contradict projections from CMS, which said it expected a 1.03% increase for plans after factoring in a decline in payments when accounting for risk adjustment changes.
February 16, 2023
For Most of COVID-19 Pandemic, Major For-Profit Hospitals’ Operating Margins Exceeded Years Prior
HCA and Tenet in particular have had high operating margins of at least 10% and at least 5%, respectively, in nine out of 11 quarters.
December 5, 2022
MGMA Report Reveals Significant Increase in Regulatory Burden on Medical Practices
An overwhelming majority (89%) of respondents reported that the overall regulatory burden on their medical practice has increased over the past 12 months. Even more respondents (97%) agreed a reduction in regulatory burden would allow their practice to reallocate resources toward patient care.
October 13, 2022